Endocrine Patients’ Views on Transoral Endoscopic Thyroidectomy via Vestibular Approach (TOETVA)

TOETVA’s adoption has been slow in the Western hemisphere. Our study aimed to evaluate how endocrine patients in the United States perceive the risks and benefits of TOETVA. This was a cross-sectional study where a de novo survey was sent via email to patients seen from 2018 to 2020. The survey asked how each of TOETVA’s risks and benefits affect their choice between traditional thyroidectomy (TT) and TOETVA on a scale from 1 (favors TT) to 10 (favors TOETVA). Statistical significance was determined at p < 0.05. Of 422 patients (3.2% response rate), 76.0% were female, 28.9% were non-Whites, 58.3% possessing graduate/professional degrees, and 34.1% were diagnosed with thyroid cancer. Significant differences were found between groups of age, race, educational attainment, thyroid cancer diagnosis, and history of thyroid or parathyroid surgery with respect to their preference for thyroidectomy between TT and TOETVA. In multivariate analysis, attitudes towards longer operative time (estimate 0.130, 95% CI 0.026–0.235, p = 0.002), limited outcome data (estimate 0.142, 95% CI 0.029–0.254, p = 0.024), having less pain (estimate 0.108, 95% CI 0.004–0.212, p = 0.042), travel to seek care (estimate 0.166, 95% CI 0.042–0.290, p = 0.009), as well as African American race (estimate 0.714, 95% CI 0.093–1.334, p = 0.024), and history of surgery (estimate − 0.843, 95% CI − 1.364– − 0.323, p = 0.002) were independently predictive of overall preferences. TOETVA’s risks and benefits may carry varying degrees of significance in patients’ decision-making process, which helps tailor the discussion to choose the right procedure for patients.